Fundz
Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Crescendo Health Appoints David Strutton As Chief Scientific Officer

PRIVATEAug 18, 2026•about 5 hours ago

Position

Chief Scientific Officer

Company

Crescendo Health

David Strutton, PhD
Information TechnologyBiotechnologyHealth CareMedical

Description

Crescendo Health has announced the appointment of David Strutton, PhD, as Chief Scientific Officer. He will be responsible for leading the company's scientific strategy and advancing patient-centric clinical research.

Company Information

Company

Crescendo Health

About

Crescendo Health is an innovative digital health company that is transforming the way patient health data is collected and used to advance clinical research. Leveraging many of the same transformative technologies that have revolutionized patient care, Crescendo Health builds relationships with patients by garnering informed consent to collect health information on their behalf, then curates the data for trial sponsors to have a more comprehensive and longitudinal view of patient health. Founded by veteran healthcare executives from Datavant and Grand Rounds, the Crescendo Health team includes leaders from across the research, technology, academic and provider communities. The company was founded in 2021 and is backed by leading institutional and angel investors. For more information, please visit www.crescendo.health.

Don't miss Crescendo Health's next move

Get an email the moment Crescendo Health changes its leadership, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Crescendo Health's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.